StreetAlpha.app
Home › Stocks › NAGE

Niagen Bioscience, Inc. (NAGE)

Healthcare

Niagen Bioscience, Inc. (NAGE) is a Healthcare stock tracked by StreetAlpha. NAGE reports earnings on Wed, Nov 4, 2026.

AI Auto Pilots
Is NAGE in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$129.1M
+11.0% vs a year ago
Net income
$16.0M
−9.8% vs a year ago
EPS (diluted)
$0.19
−13.6% vs a year ago
Gross margin
64.2%
$82.9M gross profit
Balance sheet
Cash & equivalents
$66.7M
At Jun 30
Shareholder equity
$82.5M
Buybacks
$5.4M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $67.4M$67.4MFY2021FY2022: $72.0M$72.0MFY2022FY2023: $83.6M$83.6MFY2023FY2024: $99.6M$99.6MFY2024FY2025: $129.4M$129.4MFY2025

From NAGE's SEC filings, latest 10-Q for the period ending Jun 30, 2026 (filed Aug 4). Last 12 months adds up the four latest quarters.

Next report
Nov 4
2026 · Time not announced
Consensus EPS forecast
-$0.01
$32.3M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated NAGE in the past 90 days, not enough for a consensus
Average 12-month target
$9.00

Based on 1 analyst who set a price target on NAGE in the past 90 days. The average target is $9.00, with a high of $9.00 and a low of $9.00.

Low $9.00Avg $9.00High $9.00
Highest target$9.00
Average target$9.00
Lowest target$9.00
Latest rating changes
Canaccord GenuityMaintained
Oct 31Buy$9
DateFirmActionRatingPrice target
Oct 31Canaccord GenuityMaintainedBuy$9
Loading…

Whale Options Flow

90D

No whale options trades in NAGE in the last 90 days.

Loading…

NAGE Institutional Ownership

Hedge fund holdings →
Funds holding
140
−3 vs Q1 2026
Value held
$95.1M
32M shares
Buying vs selling
62 / 86
24 new · 26 sold out
Put/call ratio
0.00
Down from 0.00 in Q1 2026
Top holders · Q2 2026
4.2M shares$13.3M+313K
3.5M shares$11.2M+127K
2.1M shares$6.8M−2,259
2M shares$6K−21K
1.6M shares$5.2M−90K
1.5M shares$4.7M+134K
7. UBS Group AGTrimmed
1.3M shares$4.1M−122K
1.3M shares$4.0M+11K
1.2M shares$3.7M−1.2M
1.2M shares$3.7M−55K
#FundSharesValueChange
1BlackRock, Inc.4.2M$13.3M+313KAdded
2SteelPeak Wealth, LLC3.5M$11.2M+127KAdded
3Vanguard Capital Management LLC2.1M$6.8M−2,259Trimmed
4Tieton Capital Management, LLC2M$6K−21KTrimmed
5Qube Research & Technologies Ltd1.6M$5.2M−90KTrimmed
6Geode Capital Management, LLC1.5M$4.7M+134KAdded
7UBS Group AG1.3M$4.1M−122KTrimmed
8Goldman Sachs Group Inc1.3M$4.0M+11KAdded
9Arrowstreet Capital, Limited Partnership1.2M$3.7M−1.2MTrimmed
10Vanguard Portfolio Management LLC1.2M$3.7M−55KTrimmed
Biggest buyers
Biggest sellers
Filed so far for Q3 2026 · 27 funds changed their position

From SEC Form 13F filings by funds managing over $100 million, as of Jun 30, 2026. Changes compare each fund with its own Q1 2026 filing. Filings come up to 45 days after the quarter ends. Put/call compares the value of puts and calls funds reported ($0 in puts, $153K in calls), leaving out market makers and bank trading desks. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NAGE is in one of them and how their past NAGE trades turned out.

NAGE in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NAGE in an article yet. Here's the latest on the wider market.